Reutlinger M - Search Results

1

Voyages to the (un)known: adaptive design of bioactive compounds.

Schneider G, Hartenfeller M, Reutlinger M, Tanrikulu Y, Proschak E, Schneider P. Schneider G, et al. Among authors: reutlinger m. Trends Biotechnol. 2009 Jan;27(1):18-26. doi: 10.1016/j.tibtech.2008.09.005. Epub 2008 Nov 10. Trends Biotechnol. 2009. PMID: 19004513 Review.

2

Multi-objective molecular de novo design by adaptive fragment prioritization.

Reutlinger M, Rodrigues T, Schneider P, Schneider G. Reutlinger M, et al. Angew Chem Int Ed Engl. 2014 Apr 14;53(16):4244-8. doi: 10.1002/anie.201310864. Epub 2014 Mar 12. Angew Chem Int Ed Engl. 2014. PMID: 24623390

3

Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.

Schneider G, Geppert T, Hartenfeller M, Reisen F, Klenner A, Reutlinger M, Hähnke V, Hiss JA, Zettl H, Keppner S, Spänkuch B, Schneider P. Schneider G, et al. Among authors: reutlinger m. Future Med Chem. 2011 Mar;3(4):415-24. doi: 10.4155/fmc.11.8. Future Med Chem. 2011. PMID: 21452978

4

Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery.

Reutlinger M, Schneider G. Reutlinger M, et al. J Mol Graph Model. 2012 Apr;34:108-17. doi: 10.1016/j.jmgm.2011.12.006. Epub 2012 Jan 2. J Mol Graph Model. 2012. PMID: 22326864 Review.

5

Combining on-chip synthesis of a focused combinatorial library with computational target prediction reveals imidazopyridine GPCR ligands.

Reutlinger M, Rodrigues T, Schneider P, Schneider G. Reutlinger M, et al. Angew Chem Int Ed Engl. 2014 Jan 7;53(2):582-5. doi: 10.1002/anie.201307786. Epub 2013 Nov 26. Angew Chem Int Ed Engl. 2014. PMID: 24282133

6

Adaptive peptide design.

Schneider G, Lin YC, Koch CP, Pillong M, Perna AM, Reutlinger M, Hiss JA. Schneider G, et al. Among authors: reutlinger m. Chimia (Aarau). 2013;67(12-13):859-63. doi: 10.2533/chimia.2013.859. Chimia (Aarau). 2013. PMID: 24594327 Free article.

7

Designing Multi-target Compound Libraries with Gaussian Process Models.

Bieler M, Reutlinger M, Rodrigues T, Schneider P, Kriegl JM, Schneider G. Bieler M, et al. Among authors: reutlinger m. Mol Inform. 2016 May;35(5):192-8. doi: 10.1002/minf.201501012. Epub 2016 Mar 2. Mol Inform. 2016. PMID: 27492085

8

Neighborhood-preserving visualization of adaptive structure-activity landscapes: application to drug discovery.

Reutlinger M, Guba W, Martin RE, Alanine AI, Hoffmann T, Klenner A, Hiss JA, Schneider P, Schneider G. Reutlinger M, et al. Angew Chem Int Ed Engl. 2011 Dec 2;50(49):11633-6. doi: 10.1002/anie.201105156. Epub 2011 Oct 7. Angew Chem Int Ed Engl. 2011. PMID: 21984024 No abstract available.

9

Drugs by numbers: reaction-driven de novo design of potent and selective anticancer leads.

Spänkuch B, Keppner S, Lange L, Rodrigues T, Zettl H, Koch CP, Reutlinger M, Hartenfeller M, Schneider P, Schneider G. Spänkuch B, et al. Among authors: reutlinger m. Angew Chem Int Ed Engl. 2013 Apr 22;52(17):4676-81. doi: 10.1002/anie.201206897. Epub 2012 Nov 20. Angew Chem Int Ed Engl. 2013. PMID: 23166089

10

Combinatorial chemistry by ant colony optimization.

Hiss JA, Reutlinger M, Koch CP, Perna AM, Schneider P, Rodrigues T, Haller S, Folkers G, Weber L, Baleeiro RB, Walden P, Wrede P, Schneider G. Hiss JA, et al. Among authors: reutlinger m. Future Med Chem. 2014 Mar;6(3):267-80. doi: 10.4155/fmc.13.203. Future Med Chem. 2014. PMID: 24575965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page